市場調查報告書

藥物·疫苗鼻腔內給藥- 全球市場的展望(2019年∼2027年)

Intranasal Drug and Vaccine Delivery - Global Market Outlook (2019 -2027)

出版商 Stratistics Market Research Consulting 商品編碼 956134
出版日期 內容資訊 英文 174 Pages
商品交期: 2-3個工作天內
價格
藥物·疫苗鼻腔內給藥- 全球市場的展望(2019年∼2027年) Intranasal Drug and Vaccine Delivery - Global Market Outlook (2019 -2027)
出版日期: 2020年08月01日內容資訊: 英文 174 Pages
簡介

全球藥物·疫苗鼻腔內給藥市場在2019年估算為462億美元,在預測期間內預計將以8.5%的年複合成長率推移,2027年之前達到887億5,000萬美元規模。對鼻產品的偏愛不斷增加,呼吸系統疾病和神經系統疾病的流行以及鼻內產品投放市場的激增是推動市場增長的關鍵因素。然而,與鼻產品使用相關的中度並發症和副作用阻礙了市場的增長。

本報告提供藥物·疫苗鼻腔內給藥市場調查,提供市場概要,市場成長要素及阻礙因素分析,各類型·各產品·各用途·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 產品分析
  • 用途分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 藥物·疫苗鼻腔內給藥的全球市場:各產品

  • 液體供給設備
  • 粉末供給設備
  • 加壓式定量吸入器

第6章 全球藥物·疫苗鼻腔內給藥市場:劑量

  • 多劑量
  • 單位用量

第7章 全球藥物·疫苗鼻腔內給藥市場:各用途

  • 神經病變
  • 疼痛管理
  • 呼吸疾病
  • 疫苗接種

第8章 全球藥物·疫苗鼻腔內給藥市場:各流通管道

  • 醫院藥局
  • 線上藥局
  • 零售藥局

第9章 全球藥物·疫苗鼻腔內給藥市場: 各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和近東及非洲的其他中東的地區

第10章 主要發展

  • 契約,夥伴關係,合作,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第11章 企業簡介

  • 3M
  • Aptar Pharma
  • Bespak
  • GlaxoSmithKline Plc
  • Intersect ENT
  • OptiNose, Inc.
  • Teleflex Corporation
  • Teva Pharmaceuticals
  • UCB, Inc.
目錄

According to Stratistics MRC, the Global Intranasal Drug and Vaccine Delivery Market is accounted for $46.20 billion in 2019 and is expected to reach $88.75 billion by 2027 growing at a CAGR of 8.5% during the forecast period. Growing preference for nasal products, increasing prevalence of respiratory and neurological diseases, and surge in intranasal product launches are the major factors propelling the market growth. However, moderate complications and side effects associated with the use of nasal products are hampering the market growth.

Drug delivery refers to a process of delivering a drug into the patient's body to have an effective therapeutic effect. Different modes are used for the delivery of drug. Nasal and pulmonary routes are most popular modes for delivering drug. The global drug delivery market is growing at a significant rate due to growing awareness in the field and technical innovations in the field. Intranasal drug delivery refers to a process of delivering the administered drug through nasal route. Drugs that are delivering through nasal means may be prescribed for acute or chronic treatments. Various types of drugs that are delivered through nasal cavity are local anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, snuffs, antihistamines and others.

Based on the distribution channel, the online pharmacies segment is going to have a lucrative growth during the forecast period due to the discounts offered, as well as cost-effectiveness to patients and payers in the long run. Moreover, increasing inclination towards online purchases has brought advantages to the online pharmacies segment.

By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the increasing product development protocols, economic growth, and increase in the number of local market players involved in the development of novel drug delivery systems. China and India are expected to be the fastest growing intranasal drug delivery markets in Asian region. This is due to large investment by various major companies in these countries. Some of the key driving forces for intranasal drug delivery market in emerging countries are large pool of patients, rising government funding and improvement in the healthcare facilities.

Some of the key players profiled in the Intranasal Drug and Vaccine Delivery Market include 3M, Aptar Pharma, Bespak, GlaxoSmithKline Plc, Intersect ENT, OptiNose, Inc., Teleflex Corporation, Teva Pharmaceuticals, and UCB, Inc.

Products Covered:

  • Liquid Delivery Device
  • Powder Delivery Device
  • Pressurized Metered Dose Inhaler

Dosages Covered:

  • Multi-Dose
  • Unit-Dose

Applications Covered:

  • Neurological Disorder
  • Pain Management
  • Respiratory Disorders
  • Vaccination

Distribution Channels Covered:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019 2020, 2024, and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Intranasal Drug and Vaccine Delivery Market, By Product

  • 5.1 Introduction
  • 5.2 Liquid Delivery Device
  • 5.3 Powder Delivery Device
  • 5.4 Pressurized Metered Dose Inhaler

6 Global Intranasal Drug and Vaccine Delivery Market, By Dosage

  • 6.1 Introduction
  • 6.2 Multi-Dose
  • 6.3 Unit-Dose

7 Global Intranasal Drug and Vaccine Delivery Market, By Application

  • 7.1 Introduction
  • 7.2 Neurological Disorder
  • 7.3 Pain Management
  • 7.4 Respiratory Disorders
  • 7.5 Vaccination

8 Global Intranasal Drug and Vaccine Delivery Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hospital Pharmacies
  • 8.3 Online Pharmacies
  • 8.4 Retail Pharmacies

9 Global Intranasal Drug and Vaccine Delivery Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 3M
  • 11.2 Aptar Pharma
  • 11.3 Bespak
  • 11.4 GlaxoSmithKline Plc
  • 11.5 Intersect ENT
  • 11.6 OptiNose, Inc.
  • 11.7 Teleflex Corporation
  • 11.8 Teva Pharmaceuticals
  • 11.9 UCB, Inc.

List of Tables

  • Table 1 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)
  • Table 3 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
  • Table 4 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
  • Table 5 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)
  • Table 6 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)
  • Table 7 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)
  • Table 8 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)
  • Table 9 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)
  • Table 10 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
  • Table 11 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
  • Table 12 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
  • Table 13 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)
  • Table 14 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
  • Table 15 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
  • Table 16 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
  • Table 17 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
  • Table 18 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)
  • Table 19 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)
  • Table 20 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
  • Table 21 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
  • Table 22 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)
  • Table 23 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)
  • Table 24 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)
  • Table 25 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)
  • Table 26 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)
  • Table 27 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
  • Table 28 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
  • Table 29 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
  • Table 30 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)
  • Table 31 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
  • Table 32 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
  • Table 33 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
  • Table 34 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
  • Table 35 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)
  • Table 36 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)
  • Table 37 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
  • Table 38 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
  • Table 39 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)
  • Table 40 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)
  • Table 41 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)
  • Table 42 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)
  • Table 43 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)
  • Table 44 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
  • Table 45 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
  • Table 46 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
  • Table 47 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)
  • Table 48 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
  • Table 49 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
  • Table 50 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
  • Table 51 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
  • Table 52 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)
  • Table 53 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)
  • Table 54 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
  • Table 55 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
  • Table 56 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)
  • Table 57 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)
  • Table 58 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)
  • Table 59 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)
  • Table 60 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)
  • Table 61 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
  • Table 62 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
  • Table 63 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
  • Table 64 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)
  • Table 65 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
  • Table 66 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
  • Table 67 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
  • Table 68 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
  • Table 69 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)
  • Table 70 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)
  • Table 71 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
  • Table 72 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
  • Table 73 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)
  • Table 74 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)
  • Table 75 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)
  • Table 76 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)
  • Table 77 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)
  • Table 78 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
  • Table 79 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
  • Table 80 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
  • Table 81 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)
  • Table 82 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
  • Table 83 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
  • Table 84 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
  • Table 85 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
  • Table 86 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)
  • Table 87 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)
  • Table 88 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
  • Table 89 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
  • Table 90 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)
  • Table 91 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)
  • Table 92 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)
  • Table 93 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)
  • Table 94 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)
  • Table 95 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
  • Table 96 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
  • Table 97 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
  • Table 98 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)
  • Table 99 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
  • Table 100 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
  • Table 101 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
  • Table 102 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)